Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| oligodendrocyte | 16 studies | 56% ± 19% | |
| endothelial cell | 6 studies | 38% ± 20% | |
| retinal pigment epithelial cell | 3 studies | 30% ± 4% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 7 studies | 33% ± 12% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| brain | 99% | 7925.57 | 2623 / 2642 | 93% | 18.85 | 656 / 705 |
| liver | 15% | 144.95 | 33 / 226 | 32% | 1.29 | 128 / 406 |
| lung | 7% | 53.08 | 38 / 578 | 33% | 1.15 | 378 / 1155 |
| prostate | 0% | 0 | 0 / 245 | 36% | 2.10 | 179 / 502 |
| esophagus | 0% | 0 | 0 / 1445 | 36% | 1.31 | 65 / 183 |
| ovary | 0% | 0 | 0 / 180 | 25% | 0.72 | 107 / 430 |
| bladder | 0% | 0 | 0 / 21 | 17% | 0.46 | 84 / 504 |
| tonsil | 0% | 0 | 0 / 0 | 16% | 0.46 | 7 / 45 |
| skin | 0% | 0.70 | 2 / 1809 | 9% | 0.28 | 44 / 472 |
| kidney | 2% | 14.39 | 2 / 89 | 5% | 0.20 | 48 / 901 |
| breast | 4% | 32.27 | 19 / 459 | 3% | 0.16 | 38 / 1118 |
| uterus | 0% | 0 | 0 / 170 | 7% | 0.21 | 33 / 459 |
| pancreas | 0% | 0 | 0 / 328 | 6% | 0.15 | 11 / 178 |
| thymus | 0% | 1.48 | 1 / 653 | 5% | 0.18 | 29 / 605 |
| stomach | 0% | 0 | 0 / 359 | 5% | 0.10 | 13 / 286 |
| intestine | 0% | 0.59 | 1 / 966 | 4% | 0.09 | 19 / 527 |
| lymph node | 0% | 0 | 0 / 0 | 3% | 0.11 | 1 / 29 |
| eye | 0% | 0 | 0 / 0 | 1% | 0.09 | 1 / 80 |
| adrenal gland | 0% | 0 | 0 / 258 | 0% | 0.02 | 1 / 230 |
| spleen | 0% | 2.37 | 1 / 241 | 0% | 0 | 0 / 0 |
| heart | 0% | 0.82 | 1 / 861 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| adipose | 0% | 0 | 0 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 0% | 0 | 0 / 1335 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| muscle | 0% | 0 | 0 / 803 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0015721 | Biological process | bile acid and bile salt transport |
| GO_0006811 | Biological process | monoatomic ion transport |
| GO_0043252 | Biological process | sodium-independent organic anion transport |
| GO_0015695 | Biological process | organic cation transport |
| GO_0006805 | Biological process | xenobiotic metabolic process |
| GO_0015711 | Biological process | organic anion transport |
| GO_0055085 | Biological process | transmembrane transport |
| GO_0016324 | Cellular component | apical plasma membrane |
| GO_0009925 | Cellular component | basal plasma membrane |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0016323 | Cellular component | basolateral plasma membrane |
| GO_0015125 | Molecular function | bile acid transmembrane transporter activity |
| GO_0008514 | Molecular function | organic anion transmembrane transporter activity |
| GO_0015347 | Molecular function | sodium-independent organic anion transmembrane transporter activity |
| GO_0015101 | Molecular function | organic cation transmembrane transporter activity |
| GO_0022857 | Molecular function | transmembrane transporter activity |
| Gene name | SLCO1A2 |
| Protein name | Solute carrier organic anion transporter family member 1A2 Solute carrier organic anion transporter family member 1A2 (OATP1A2) (OATP-A) (Organic anion-transporting polypeptide 1) (OATP-1) (Sodium-independent organic anion transporter) (Solute carrier family 21 member 3) Solute carrier organic anion transporter family member |
| Synonyms | OATP1A2 SLC21A3 OATP1 OATP |
| Description | FUNCTION: Na(+)-independent transporter that mediates the cellular uptake of a broad range of organic anions such as the endogenous bile salts cholate and deoxycholate, either in their unconjugated or conjugated forms (taurocholate and glycocholate), at the plasmam membrane . Responsible for intestinal absorption of bile acids (By similarity). Transports dehydroepiandrosterone 3-sulfate (DHEAS), a major circulating steroid secreted by the adrenal cortex, as well as estrone 3-sulfate and 17beta-estradiol 17-O-(beta-D-glucuronate) . Mediates apical uptake of all-trans-retinol (atROL) across human retinal pigment epithelium, which is essential to maintaining the integrity of the visual cycle and thus vision . Involved in the uptake of clinically used drugs . Capable of thyroid hormone transport (both T3 or 3,3',5'-triiodo-L-thyronine, and T4 or L-tyroxine) . Also transports prostaglandin E2 . Plays roles in blood-brain and -cerebrospinal fluid barrier transport of organic anions and signal mediators, and in hormone uptake by neural cells (By similarity). May also play a role in the reuptake of neuropeptides such as substance P/TAC1 and vasoactive intestinal peptide/VIP released from retinal neurons . May play an important role in plasma and tissue distribution of the structurally diverse chemotherapeutic drugs methotrexate and paclitaxel . Shows a pH-sensitive substrate specificity which may be ascribed to the protonation state of the binding site and leads to a stimulation of substrate transport in an acidic microenvironment . Hydrogencarbonate/HCO3(-) acts as the probable counteranion that exchanges for organic anions . May contribute to regulate the transport of organic compounds in testis across the blood-testis-barrier (Probable). . |
| Accessions | C9JTF6 C9IYW8 B4DJE6 ENST00000416627.1 ENST00000422327.5 ENST00000445053.1 P46721 C9JCA7 Q8IV69 ENST00000435179.5 ENST00000544020.5 ENST00000544290.5 F5H060 F5GXY6 ENST00000413682.5 C9JG34 ENST00000450590.5 ENST00000453443.5 C9JUW6 C9JSB7 C9JHU9 C9K059 ENST00000683939.1 [P46721-1] ENST00000307378.10 [P46721-1] ENST00000458504.5 ENST00000421287.5 |